An open-label, multicenter, efficacy, and safety study of deferasirox in iron-overloaded patients with non-transfusion-dependent thalassemia (THETIS): 5-year results

MeSH terms

• Benzoates / adverse effects
• Deferasirox / adverse effects
• Humans
• Iron
• Iron Chelating Agents / adverse effects
• Iron Overload* / drug therapy
• Iron Overload* / etiology
• Thalassemia* / complications
• Thalassemia* / drug therapy
• beta-Thalassemia* / complications
• beta-Thalassemia* / drug therapy